Latest news with #EdelsonLechtzinLLP
Yahoo
a day ago
- Business
- Yahoo
Cable One, Inc. (CABO) Faces Legal Scrutiny from Edelson Lechtzin LLP
Citing possible breaches of federal securities regulations, Edelson Lechtzin LLP has launched an investigation into Cable One, Inc. (NYSE:CABO). The inquiry follows serious concerns regarding potential misrepresentation of the company's operational outlook ahead of its first-quarter earnings announcement, which sharply missed analyst expectations and resulted in a market backlash. A customer in their home enjoying premium channels, high-definition set-top boxes, and whole-home DVRs. On May 1, 2025, Cable One, Inc. (NYSE:CABO) disclosed disappointing Q1 figures and said it would suspend its previously anticipated dividend. These results and announcements, deviating from the earlier guidance, prompted skepticism from analysts at KeyBanc and Raymond James, who criticized the company's previous forecasts on subscriber and broadband revenue growth. The stock quickly plummeted by 41.79%, reaching $152.51 per share on May 2. Having launched an inquiry on Cable One, Inc. (NYSE:CABO), Edelson Lechtzin LLP calls for those with non-public information related to the company to come forward and assist in the investigation. The probe has been initiated amid CEO Julia M. Laulis's retirement. Laulis has held on to the role for more than two decades at Cable One, Inc. (NYSE:CABO) and has over 40 years of expertise in the cable sector. Founded in Arizona, Cable One, Inc. (NYSE:CABO) delivers broadband internet, voice, and video services across underserved regions in the U.S. The company's core operations are centered around subscriber growth and infrastructure upgrades, areas that are now under investor scrutiny. While we acknowledge the potential of CABO as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the best short-term AI stock. READ NEXT: 10 Unstoppable Dividend Stocks to Buy Now and 11 Oversold Global Stocks to Buy According to Hedge Funds Disclosure: None. Sign in to access your portfolio
Yahoo
a day ago
- Business
- Yahoo
Semler Scientific, Inc. (SMLR) Faces Scrutiny from Edelson Lechtzin LLP
On June 4, 2025, Edelson Lechtzin LLP announced that it has initiated an inquiry into whether the healthcare technology company, Semler Scientific, Inc. (NASDAQ:SMLR), misled investors about its business operations regarding claims tied to its QuantaFlo diagnostic device. A doctor in focus surrounded by colleagues in a hospital setting. In an annual report filed by Semler Scientific, Inc. (NASDAQ:SMLR) on February 28, 2025, the company disclosed that the U.S. Department of Justice (DOJ) was evaluating a potential False Claims Act case. The report triggered immediate market reaction, with the company's shares plummeting by 9.4% to close at $38.89 on March 3. Initiating the inquiry, Edelson Lechtzin LLP has asked for the public and stakeholders' help. Edelson urges those with non-public information regarding Semler Scientific, Inc. (NASDAQ:SMLR) to come forward and assist them in the investigation. It also encourages the company's investors who have suffered losses to follow the inquiry to learn more. The investor confidence has been significantly fluctuating since the disclosure. The stock's performance, which gained 6.49% last month, declined by 13.46% last week. The California-based company, Semler Scientific, Inc. (NASDAQ:SMLR), is known for developing non-invasive medical tools, with QuantaFlo being its most prominent product. Focusing on early disease detection and chronic condition management, the company has positioned itself between healthcare and technology. While we acknowledge the potential of SMLR as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the best short-term AI stock. READ NEXT: 10 Unstoppable Dividend Stocks to Buy Now and 11 Oversold Global Stocks to Buy According to Hedge Funds Disclosure: None. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Malaysian Reserve
2 days ago
- Business
- Malaysian Reserve
INVESTIGATION ALERT: Edelson Lechtzin LLP Announces Investigation Of Luminar Technologies, Inc. (NASDAQ: LAZR) and Encourages Investors with Substantial Losses or Witnesses with Relevant Information t
NEWTOWN, Pa., June 4, 2025 /PRNewswire/ — Edelson Lechtzin LLP is investigating potential violations of the federal securities laws involving Luminar Technologies, Inc. ('Luminar') (NASDAQ: LAZR), resulting from allegations of providing potentially misleading business information to the investing public. If you have non-public information that could assist in the Luminar investigation, or if you are a Luminar investor who suffered a loss and would like to learn more, you can provide your information HERE. You can also contact attorney Eric Lechtzin of Edelson Lechtzin LLP by calling 844-563-5550 or via e-mail at elechtzin@ THE COMPANY: Luminar Technologies is an automotive technology company developing advanced sensors, software, and safety systems for autonomous vehicles. THE ALLEGED WRONGDOING: On May 14, 2025, Luminar published a press release announcing the resignation of company founder, President, and CEO Austin Russell, effective immediately. According to the press release, Russell's resignation resulted from a business conduct and ethics inquiry conducted by an internal audit committee. Following publication of the press release, Luminar's stock price fell $0.80 per share, or 16.81%, to close at $3.96 per share on May 15, 2025. ABOUT EDELSON LECHTZIN LLP: Edelson Lechtzin LLP is a national class action law firm with offices in Pennsylvania and California. In addition to cases involving securities and investment fraud, our lawyers focus on class cases alleging violations of the federal antitrust laws, employee benefit plans under ERISA, wage theft, data security, and consumer fraud. For more information, please contact: Marc H. Edelson, Lechtzin, LECHTZIN LLP411 S. State Street, Suite N-300Newtown, PA 18940Phone: 844-696-7492 or 215-867-2399 ext. 1Email: medelson@ Email: elechtzin@ Web: This press release may be considered Attorney Advertising in some jurisdictions. No class has been certified in this case, so you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. Your ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.
Malaysian Reserve
19-05-2025
- Business
- Malaysian Reserve
DATA BREACH ALERT: Edelson Lechtzin LLP Is Investigating Claims On Behalf Of Harbin Clinic, LLC (incident experienced by the reporting entity's vendor, Nationwide Recovery Services, Inc.) Customers Wh
NEWTOWN, Pa., May 19, 2025 /PRNewswire/ — The law firm of Edelson Lechtzin LLP is investigating claims regarding data privacy violations at Harbin Clinic, LLC ('Harbin Clinic'). Harbin Clinic learned of suspicious activity in February 2025. To join this case, go HERE. About Harbin Clinic, LLC Harbin Clinic, LLC is a physician-directed medical group in Georgia offering a wide range of healthcare services What happened? Harbin Clinic was recently notified by Nationwide Recovery Services (NRS), a third-party debt recovery and financial services provider, about a cybersecurity breach that may have exposed personal data belonging to some of its patients. The breach stemmed from suspicious activity detected in July 2024, which caused a system disruption at NRS. An investigation revealed that between July 5 and July 11, unauthorized individuals accessed the network and copied certain files. In February 2025, NRS informed Harbin Clinic that patient data might have been affected by the breach. Up to 210,140 individuals have been affected by this breach. What type of information was stolen? The personal information in the compromised files may have included: Names Addresses Social Security Numbers Dates of Birth Financial Account Information How can I protect my personal data? If you receive a data breach notification concerning Harbin Clinic you must guard against possible misuse of your personal information, including identity theft and fraud, by regularly reviewing your account statements and monitoring your credit reports for suspicious or unauthorized activity. Edelson Lechtzin LLP is investigating a class action lawsuit to seek legal remedies for individuals whose sensitive personal data may have been compromised by the Harbin Clinic data breach. For more information, please contact: Marc H. Edelson, LECHTZIN LLP411 S. State Street, Suite N-300Newtown, PA 18940Phone: 844-696-7492 ext. 2Email: medelson@ About Edelson Lechtzin LLP Edelson Lechtzin LLP is a national class action law firm with offices in Pennsylvania and California. In addition to cases involving data breaches, our lawyers focus on class and collective litigation in cases alleging securities and investment fraud, violations of the federal antitrust laws, employee benefit plans under ERISA, wage theft and unpaid overtime, consumer fraud, and catastrophic injuries. This press release may be considered Attorney Advertising in some jurisdictions.
Associated Press
19-03-2025
- Business
- Associated Press
DATA BREACH ALERT: Edelson Lechtzin LLP Is Investigating Claims On Behalf Of California Cryobank LLC Customers Whose Data May Have Been Compromised
NEWTOWN, Pa., March 19, 2025 (GLOBE NEWSWIRE) -- Edelson Lechtzin LLP, a national class action law firm, is investigating data privacy violations at California Cryobank LLC ('CCB'). CCB learned of unauthorized activity on its computer network between April 20, 2024, and April 22, 2024. To join this case, go HERE. About California Cryobank LLC California Cryobank, a unit of CooperSurgical, specializes in reproductive tissue preservation, including donor sperm and egg services, long-term storage, and cord blood banking. What happened? Between April 20, 2024, and April 22, 2024, CCB experienced a cyber security incident involving unauthorized activity on its IT network. The company launched an investigation and discovered that certain files containing sensitive personal information may have been stolen or accessed. What type of information was stolen? The personal information in the compromised files may have included: Names Driver's License Numbers Bank Account/Routing Numbers Payment Card Numbers How can I protect my personal data? If you receive a data breach notification concerning CCB, you must guard against possible misuse of your personal information, including identity theft and fraud, by regularly reviewing your account statements and monitoring your credit reports for suspicious or unauthorized activity. Edelson Lechtzin LLP is investigating a class action lawsuit to seek legal remedies for individuals whose sensitive personal data may have been compromised by the CCB data breach. For more information, please contact: Marc H. Edelson, Esq. EDELSON LECHTZIN LLP 411 S. State Street, Suite N-300 Newtown, PA 18940 Phone: 844-696-7492 ext. 2 Email: [email protected] Web: About Edelson Lechtzin LLP Edelson Lechtzin LLP is a national class action law firm with offices in Pennsylvania and California. In addition to cases involving data breaches, our lawyers focus on class and collective litigation in cases alleging securities and investment fraud, violations of the federal antitrust laws, employee benefit plans under ERISA, wage theft and unpaid overtime, consumer fraud, and catastrophic injuries. This press release may be considered Attorney Advertising in some jurisdictions.
